Taiwan FDA registration bd93e01fa849aeb39e66fbb751ba6135
"Rhenium card" sergipax staining reagent set (unsterilized)
TW: "錸卡" 瑟基帕司染色試劑組 (未滅菌)
Taiwan·Risk Class 1·LEICA BIOSYSTEMS RICHMOND INC.·Registered Oct 01, 2021 – Oct 31, 2025ExpiredRegistration details
- Analysis ID
- bd93e01fa849aeb39e66fbb751ba6135
- Customs Code
- DHA08401351100
Company information
- Manufacturer
- LEICA BIOSYSTEMS RICHMOND INC.
- Manufacturer Country
- United States
- Authorized Representative
- ALL PROMISE ENTERPRISE INC.
Product details
- Intended Use
- Limited to the first grade identification range of medical equipment classification and grading management methods dyes and chemical solution dyes (B.1850).
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.1850 Dyes and dyes for chemical solutions
- Import Information
- import
Dates and status
- Registration Date
- Oct 01, 2021
- Expiry Date
- Oct 31, 2025
About this record
Access comprehensive regulatory information for "Rhenium card" sergipax staining reagent set (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number bd93e01fa849aeb39e66fbb751ba6135 and manufactured by LEICA BIOSYSTEMS RICHMOND INC.. The authorized representative in Taiwan is ALL PROMISE ENTERPRISE INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices